USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$4.83M
Market Cap
0.0005
P/E Ratio
2680.54
EPS
$381.10
52 Week High
$1.40
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$352K |
Total Revenue | $0 |
Cost Of Revenue | $352K |
Costof Goods And Services Sold | $352K |
Operating Income | -$25M |
Selling General And Administrative | $10M |
Research And Development | $14M |
Operating Expenses | $24M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $352K |
Income Before Tax | -$24M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$24M |
Comprehensive Income Net Of Tax | - |
Ebit | -$24M |
Ebitda | -$24M |
Net Income | -$24M |
Field | Value (USD) |
---|---|
Total Assets | $16M |
Total Current Assets | $11M |
Cash And Cash Equivalents At Carrying Value | $8.7M |
Cash And Short Term Investments | $8.7M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $4.9M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $1.9M |
Other Non Current Assets | - |
Total Liabilities | $11M |
Total Current Liabilities | $6.2M |
Current Accounts Payable | $3.1M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $4.6M |
Capital Lease Obligations | $4.6M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $4.6M |
Other Current Liabilities | $3.2M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $4.8M |
Treasury Stock | - |
Retained Earnings | -$248M |
Common Stock | $84K |
Common Stock Shares Outstanding | $14K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$24M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $352K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $16M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$24M |
Field | Value (USD) |
---|---|
Gross Profit | -$352K |
Total Revenue | $0 |
Cost Of Revenue | $352K |
Costof Goods And Services Sold | $352K |
Operating Income | -$25M |
Selling General And Administrative | $10M |
Research And Development | $14M |
Operating Expenses | $24M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $352K |
Income Before Tax | -$24M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$24M |
Comprehensive Income Net Of Tax | - |
Ebit | -$24M |
Ebitda | -$24M |
Net Income | -$24M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company is headquartered in Seattle, Washington.